ameren8k05012009.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):
 May 1, 2009

AMEREN CORPORATION
(Exact name of registrant as specified in its charter)


Missouri
1-14756
43-1723446
(State or other jurisdiction
(Commission
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)



1901 Chouteau Avenue, St. Louis, Missouri 63103
(Address of principal executive offices and Zip Code)



Registrant’s telephone number, including area code:  (314) 621-3222

 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
     [  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


ITEM 2.02  Results of Operations and Financial Condition.

On May 1, 2009, Ameren Corporation (“Ameren”) issued a press release announcing its earnings for the quarterly period ended March 31, 2009.  The press release is attached as Exhibit 99.1 and is incorporated herein by reference.  The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Ameren under the Securities Act of 1933 or the Exchange Act.


ITEM 8.01  Other Events.

In its press release dated May 1, 2009, Ameren disclosed the following unaudited consolidated financial statements:  Statement of Income for the three months ended March 31, 2009 and March 31, 2008, Statement of Cash Flows for the three months ended March 31, 2009 and March 31, 2008 and Balance Sheet at March 31, 2009 and December 31, 2008.  The foregoing consolidated financial statements are attached as Exhibit 99.2 and Ameren hereby incorporates such consolidated financial statements into this Item 8.01 of this Current Report on Form 8-K.


ITEM 9.01  Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number:
Title:
 
99.1­*
Press release regarding earnings for the quarterly period ended
March 31, 2009, issued on May 1, 2009 by Ameren.
 
99.2
Ameren’s unaudited consolidated Statement of Income for the
three months ended March 31, 2009 and March 31, 2008,
Statement of Cash Flows for the three months ended March 31,
2009 and March 31, 2008 and Balance Sheet at March 31, 2009
and December 31, 2008.

 

__________________________ 
­ Exhibit 99.1 is intended to be deemed furnished rather than filed pursuant to General Instruction B.2. of Form 8-K.

 
2
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Ameren has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 

 
AMEREN CORPORATION
(Registrant)
 

 
   /s/ Martin J. Lyons                                              
By:   Martin J. Lyons
         Senior Vice President and Chief Financial Officer


 

 

Date:  May 1, 2009
 
 
3
 
Exhibit Index
 

Exhibit Number:
Title:
 
99.1­*
Press release regarding earnings for the quarterly period ended
March 31, 2009, issued on May 1, 2009 by Ameren.
 

99.2
Ameren’s unaudited consolidated Statement of Income for the
three months ended March 31, 2009 and March 31, 2008,
Statement of Cash Flows for the three months ended March 31,
2009 and March 31, 2008 and Balance Sheet at March 31, 2009
and December 31, 2008.

 

__________________________ 
­ *Exhibit 99.1 is intended to be deemed furnished rather than filed pursuant to General Instruction B.2 of Form 8-K.


4